Search...
CHINARES PHARMA: CR Sanjiu's net profit for the first three quarters is approximately 2.899 billion yuan, a year-on-year decrease of 10.65%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, CR Sanjiu announced its performance for the first three quarters of 2025, with total operating revenue of approximately 21.986 billion yuan, a year-on-year increase of 11.38%; net profit of approximately 2.899 billion yuan, a year-on-year decrease of 10.65%
According to the Zhitong Finance APP, CR Sanjiu (03320) announced its performance for the first three quarters of 2025, with total operating revenue of approximately 21.986 billion yuan, a year-on-year increase of 11.38%; net profit of approximately 2.899 billion yuan, a year-on-year decrease of 10.65%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments